1. Home
  2. MDWD vs ELMD Comparison

MDWD vs ELMD Comparison

Compare MDWD & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • ELMD
  • Stock Information
  • Founded
  • MDWD 2000
  • ELMD 1992
  • Country
  • MDWD Israel
  • ELMD United States
  • Employees
  • MDWD N/A
  • ELMD N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MDWD Health Care
  • ELMD Health Care
  • Exchange
  • MDWD Nasdaq
  • ELMD Nasdaq
  • Market Cap
  • MDWD 208.2M
  • ELMD 169.4M
  • IPO Year
  • MDWD 2014
  • ELMD 2010
  • Fundamental
  • Price
  • MDWD $16.70
  • ELMD $24.53
  • Analyst Decision
  • MDWD Strong Buy
  • ELMD Strong Buy
  • Analyst Count
  • MDWD 2
  • ELMD 2
  • Target Price
  • MDWD $35.00
  • ELMD $35.50
  • AVG Volume (30 Days)
  • MDWD 94.5K
  • ELMD 69.4K
  • Earning Date
  • MDWD 08-14-2025
  • ELMD 08-26-2025
  • Dividend Yield
  • MDWD N/A
  • ELMD N/A
  • EPS Growth
  • MDWD N/A
  • ELMD 46.55
  • EPS
  • MDWD N/A
  • ELMD 0.85
  • Revenue
  • MDWD $19,858,000.00
  • ELMD $64,000,000.00
  • Revenue This Year
  • MDWD $20.37
  • ELMD $11.25
  • Revenue Next Year
  • MDWD $25.91
  • ELMD $8.82
  • P/E Ratio
  • MDWD N/A
  • ELMD $29.05
  • Revenue Growth
  • MDWD N/A
  • ELMD 16.97
  • 52 Week Low
  • MDWD $14.14
  • ELMD $15.06
  • 52 Week High
  • MDWD $22.51
  • ELMD $35.56
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 28.98
  • ELMD 75.99
  • Support Level
  • MDWD $16.62
  • ELMD $18.86
  • Resistance Level
  • MDWD $17.35
  • ELMD $25.33
  • Average True Range (ATR)
  • MDWD 0.73
  • ELMD 0.91
  • MACD
  • MDWD -0.08
  • ELMD 0.66
  • Stochastic Oscillator
  • MDWD 5.13
  • ELMD 87.75

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: